165 related articles for article (PubMed ID: 10571026)
1. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
Lingwood CA
Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
[TBL] [Abstract][Full Text] [Related]
2. Verotoxin receptor glycolipid in human renal tissue.
Boyd B; Lingwood C
Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
[TBL] [Abstract][Full Text] [Related]
3. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
Takagi C; Naruse T
Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
[TBL] [Abstract][Full Text] [Related]
4. Verotoxin-binding in human renal sections.
Lingwood CA
Nephron; 1994; 66(1):21-8. PubMed ID: 8107950
[TBL] [Abstract][Full Text] [Related]
5. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
6. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
7. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia.
Lingwood CA
Biosci Rep; 1999 Oct; 19(5):345-54. PubMed ID: 10763802
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
9. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
10. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
Peter MG; Lingwood CA
Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
[TBL] [Abstract][Full Text] [Related]
11. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
Lingwood CA; Yiu SK
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
[TBL] [Abstract][Full Text] [Related]
12. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
Nyholm PG; Brunton JL; Lingwood CA
Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
[TBL] [Abstract][Full Text] [Related]
13. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
[TBL] [Abstract][Full Text] [Related]
14. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
Van de Kar NC; Monnens LA; Van Hinsbergh VW
Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
[TBL] [Abstract][Full Text] [Related]
16. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Mylvaganam M; Lingwood CA
Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
[TBL] [Abstract][Full Text] [Related]
17. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
18. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
Cooling LL; Walker KE; Gille T; Koerner TA
Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
[TBL] [Abstract][Full Text] [Related]
20. Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells.
Fantini J; Garmy N; Yahi N
Biochemistry; 2006 Sep; 45(36):10957-62. PubMed ID: 16953581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]